✓ No loaded language, vague sourcing, or framing detected.
A recent study published in JAMA shows that the number of patents on small-molecule drugs has tripled since 1990, with most growth in nonprimary patents. This trend contributes to higher prescription drug prices in the United States by delaying the availability of affordable generics.
Our neutral summary
A recent study published in JAMA shows that the number of patents on small-molecule drugs has tripled since 1990, with most growth in nonprimary patents. This trend contributes to higher prescription drug prices in the United States by delaying the availability of affordable generics.
The reporting belongs to Ars Technica; we don't reproduce it.
Notes are private: only you can see them.
No note attached
of yours on this article.
To keep drug prices high, pharma has been piling up the patents
Study Reveals Increase in Patents for Prescription Drugs Since 1990